Bomberger JM , Coutermarsh BA , Barnaby RL , Sato JD , Chapline MC , Stanton BA .

P20-RR016463 NCRR NIH HHS , P20-RR01878 NCRR NIH HHS , P30 DK072506 NIDDK NIH HHS , R00HL098342 NHLBI NIH HHS , R01 HL074175 NHLBI NIH HHS , P20 RR016463 NCRR NIH HHS , R00 HL098342 NHLBI NIH HHS

	Figure 2. Dexamethasone increased SGK1 protein abundance in a time-dependent manner.(A) Western blot demonstrating that the Sigma SGK1 antibody recognizes SGK1. CFBE cells were transfected with cDNA (0, no SGK1 insert), or SGK1 cDNA (0.2, 0.4, 0.6, 0.8 and 1.0 µg) and 48 hours later cells were lysed and SGK1 and ezrin were analyzed by Western blot. The SGK1 antibody recognized a protein (∼48 kDa, the predicted molecular mass of SGK1) that increases in intensity as the amount of SGK1 cDNA transfected into CFBE cells was increased. By contrast, the intensity of a non-specific protein (>50 kDa, marked by a # sign in Figure 2A), did not change as a function of the amount of SGK1 cDNA transfected in CFBE cells. (B) Representative western blot of an experiment in which CFBE cells were treated with dexamethasone (50 nM) for the indicated times at 37°C. Subsequently, cells were lysed and SGK1 and ezrin were analyzed by western blot. Data expressed as a percent of the maximum SGK1 levels observed at 4 hours (100%). Ezrin was monitored as a loading control (each lane was loaded with 50 µg of protein). # indicates a non-specific protein detected by the SGK1 antibody. The black box highlights SGK1 protein, which is also indicated by an *. (C) Summary of three experiments. Data expressed as SGK1 normalized for the amount of ezrin. *p<0.05 vs. 0 time point (no dexamethasone treatment: cells were treated with vehicle).
	Figure 3. Dexamethasone increased wt-CFTR abundance in cell lysates (A), and in the apical membrane (B).Representative western blots and data summaries are presented. (A) Cells were treated with dexamethasone (50 nM) for the indicated times at 37°C and western blot analysis was conducted to measure wt-CFTR and ezrin in cell lysates. The molecular mass of wt-CFTR is ∼180 kDa. Ezrin was monitored as a loading control. n = 7 per time point. *p<0.05 versus 0 time point. (B) Cells were treated with dexamethasone (50 nM) for the indicated time points at 37°C, and subsequently apical plasma membrane proteins were biotinylated using a technique previously described in detail by our laboratory [12], [22]. Briefly, apical membrane proteins were biotinylated at 4°C using EZ-Link™ Sulfo-NHS-SS-Biotin. Subsequently, cells were lysed, and the biotinylated proteins were isolated by streptavidin-agarose beads, eluted into SDS sample buffer, and separated by 7.5% SDS-PAGE. The blots were probed for wt-CFTR (∼180 kDa) and for ezrin, a cytoplasmic protein that was not present in the biotinylated samples, confirming that biotin is impermeable to cell membranes [12], [22], and that the procedure to determine apical membrane wt-CFTR does not detect intracellular wt-CFTR. In this and all subsequent biotinylation experiments ezrin was never detected in the biotinylated samples by western blot, demonstrating that only plasma membrane proteins were biotinylated. *p<0.05 versus 0 time point. **p<0.01 versus 0 time point.
	Figure 4. The SGK inhibitor GSK 650394 blocked the dexamethasone stimulated increase in apical membrane wt-CFTR.(A) Representative western blot, and (B) Data quantitation. CFBE cells were treated with either vehicle, GSK 650394 (100 nM), an inhibitor of SGK1, dexamethasone (50 nM), or dexamethasone (50 nM), and GSK 650394 (100 nM) for 24 hours at 37°C. The molecular mass of apical plasma membrane wt-CFTR is ∼180 kDa. Experiments performed four times. *p<0.05 versus vehicle. **p<0.05 versus dexamethasone.
	Figure 5. siSGK regulates apical plasma membrane wt-CFTR abundance.Representative western blots and data summaries are presented. (A) and (B), siSGK1 reduced SGK1 protein abundance in cells treated with dexamethasone. CFBE cells were transfected with siNeg or siSGK1, and 24 hours later treated with dexamethasone (50 nM) for 4 hours, whereupon SGK1 levels in cell lysates were measured by western blot analysis. (C) and (D), siSGK1 reduced wt-CFTR protein abundance in the apical membrane of cells treated with dexamethasone. CFBE cells were transfected with siNeg or siSGK1, and 24 hours later treated with dexamethasone (50 nM) for 4 hours, whereupon wt-CFTR levels in the apical plasma membrane were measured by plasma membrane protein biotinylation followed by western blot analysis as described in Methods. For A-D experiments performed three times. *p<0.05 versus siNeg. E and F. Constitutively active SGK1 (SGK1-S422D) increased apical membrane wt-CFTR, whereas a dominant negative, kinase inactive SGK1 (SGK1-K127N) had no effect on apical membrane wt-CFTR compared to mock (vector control). CFBE cells were transfected with either SGK1-S422D, SGK1-K127N, or vector control (mock). Ezrin was a loading control. Plasma membrane wt-CFTR was determined by biotinylation of apical membrane proteins as described in Methods. Experiments performed six times. *p<0.05 as indicated.
	Figure 6. SGK1 inhibits wt-CFTR endocytosis.(A) and (B), siRNA-mediated knockdown of SGK1 in cells treated with dexamethasone (50 nM for 4 hours) enhanced the endocytic removal of wt-CFTR from the apical membrane. CFBE cells were transfected with siSGK1 or a scrambled negative control (siNeg) and 24 hours later treated with dexamethasone (50 nM) for 4 hours. (A) Representative western blot and (B) summary of data. Wt-CFTR endocytosis was measured by a method described previously in detail and in Methods [12], [22]. In brief, in three sets of cells apical membrane proteins were biotinylated at 4°C using EZ-Link™ Sulfo-NHS-SS-Biotin. Subsequently, one set of cells (lane 1) were then lysed, and the biotinylated proteins were isolated by streptavidin-agarose beads, eluted into SDS sample buffer, separated by 7.5% SDS-PAGE, and probed for wt-CFTR and ezrin. Thus, lane 1 represents the amount of wt-CFTR in the apical membrane at time = 0. A second set of cells (lane 3) were also biotinylated at 4°C and then warmed to 37°C for 5 min to allow biotinylated wt-CFTR to be endocytosed. Subsequently, the cells were cooled to 4°C, and the disulfide bonds on Sulfo-NHS-SS-biotinylated proteins remaining in the apical membrane were reduced by GSH added to the apical solution for a total of 90 min at 4°C. The cells were then lysed, and the biotinylated proteins were isolated by streptavidin-agarose beads, eluted into SDS sample buffer, separated by 7.5% SDS-PAGE, and probed for wt-CFTR and ezrin. Thus, lane 3 represent the amount of wt-CFTR in the apical membrane at time = 0 that was endocytosed in 5 minutes. Lane 2 demonstrates that GSH reduced the disulfide bonds on Sulfo-NHS-SS-biotinylated proteins in the apical membrane. Cells in this lane were biotinylated at 4°C and the disulfide bonds on Sulfo-NHS-SS-biotinylated proteins remaining in the apical membrane were reduced by GSH added to the apical solution for a total of 90 min at 4°C. The amount of biotinylated wt-CFTR remaining in the plasma membrane after GSH treatment at 4°C and without the 37°C warming was considered background (<5% compared with the amount of biotinylated wt-CFTR at 4°C without GSH treatment, i.e., lane 1) and was subtracted from the wt-CFTR biotinylated after warming to 37°C at each time point. wt-CFTR endocytosis is reported as the amount of CFTR in lane 3 (minus background) divided by the amount in lane 1 (minus background) X 100. Quantification of three experiments. *p<0.05 versus siNeg (control). (C) and (D), Constitutively active SGK (SGK1-S422D) reduced the endocytic rate of wt-CFTR from the apical membrane compared to a dominant negative SGK1 (K127N). CFBE cells were transfected with SGK1-S422D or SGK1-K127N and wt-CFTR endocytosis was measured as described above. Representative western blot (C), and summary of the data (D). Quantification of three-six experiments. *p<0.05 versus K127N.
	Figure 7. SGK1 did not alter the recycling of endocytosed wt-CFTR from endosomes back to the apical membrane.siRNA-mediated knockdown of SGK1. (A) Representative western blot, and (B) summary of the data. The recycling assay has been described in detail previously and in Methods [12], [22]. In brief, the first three lanes in A are similar to those described in Figure 6 for the endocytosis experiments. Thus, lane 1 represents the amount of wt-CFTR in the plasma membrane at time = 0, lane 3 represents the amount of wt-CFTR endocytosed in 5 minutes and lane 2 shows that GSH cleaves the disulfide bonds on Sulfo-NHS-SS-biotinylated wt-CFTR in the apical membrane. In lane 4 cells were warmed to 37°C for 5 min after biotinylation to load endocytic vesicles with biotinylated proteins. Cells were then cooled to 4°C, and the disulfide bonds on Sulfo-NHS-SS-Biotin-labeled proteins remaining in the plasma membrane were reduced by GSH at 4°C. Subsequently, cells were warmed again to 37°C for 5 min to allow endocytosed and biotinylated wt-CFTR to recycle to the plasma membrane. Cells were then cooled again to 4°C, and the disulfide bonds on biotinylated proteins in the apical membrane were reduced with GSH. The amount of recycled wt-CFTR was calculated as the difference between the amount of biotinylated wt-CFTR after the first and second GSH treatments (minus background)×100. Experiments repeated four-five times. NS, not significant. (C) and (D), The constitutively active SGK1 (SGK1-S422D) does not alter the recycling of wt-CFTR to the apical membrane. (C) Representative western blot, and (D) Summary of the data. The recycling assay was performed as described above. Experiments repeated four-five times. NS, not significant.
	Figure 8. siSGK1 increased the amount of wt-CFTR in early endosomes, but not in recycling endosomes.Co-immunoprecipitation studies were conducted to determine the subcellular location of wt-CFTR in siNeg and siSGK1 transfected cells treated with dexamethasone (50 nM for 4 hours). EEA and Rab5a are markers of early endosomes, and Rab11a is a marker of recycling endosomes. wt-CFTR was immunoprecipitated, and co-immunoprecipitated proteins were eluted into SDS sample buffer, and separated by 7.5% SDS-PAGE. The blots were then probed for wt-CFTR, EEA, Rab5a, and Rab11. Co-immunoprecipitation of wt-CFTR with EEA1 and Rab5a identifies the amount of wt-CFTR in early endosomes, and co-immunoprecipitation of wt-CFTR with Rab11a identifies the amount of wt-CFTR in recycling endosomes. Quantification of data for Rab and EEA1 immunoprecipitation with wt-CFTR in siNeg and siSGK1 cells is normalized for the total amount of wt-CFTR immunoprecipitated. Blots in siNeg and siSGK1 experiments were cut for presentation, but were run one the same blot to allow for comparison. Lysate, the amount of EEA1, Rab5a Rab11 and wt-CFTR in cell lysates. CFTR IP, indicates IP with the anti-CFTR antibody and then western blot with the indicated antibody. IgG, immunoprecipitation with a non-specific antibody. (A) Representative western blots and (B) Summary of the data. Experiments repeated three times. *P<0.05 versus siNeg.
	Figure 9. SGK1 stimulates EGFR endocytosis.(A) and (B), Constitutively active SGK1 (S422D) increased the endocytic rate of EGFR from the apical membrane compared to a dominant negative SGK1 (K127N). CFBE cells were transfected with SGK1-S422D or SGK1-K127N and EGFR endocytosis was measured as described in detail in Methods and in Figure legends above. Representative western blot (A), and summary of the data (B). Quantification of three experiments. *P<0.05 versus K127N.
	Figure 1. Dexamethasone increased SGK1 mRNA expression in CFBE cells.Dexamethasone (50 nM for 30 minutes) increased SGK1 mRNA versus control, as determined by Q-RT-PCR. Experiments performed three times. *p<0.05.

Ameen, Endocytic trafficking of CFTR in health and disease. 2007, Pubmed

Ameen, Endocytic trafficking of CFTR in health and disease. 2007, Pubmed
Andersen, A phosphoinositide 3-kinase (PI3K)-serum- and glucocorticoid-inducible kinase 1 (SGK1) pathway promotes Kv7.1 channel surface expression by inhibiting Nedd4-2 protein. 2013, Pubmed
Barile, Large scale protein identification in intracellular aquaporin-2 vesicles from renal inner medullary collecting duct. 2005, Pubmed
Bebok, Failure of cAMP agonists to activate rescued deltaF508 CFTR in CFBE41o- airway epithelial monolayers. 2005, Pubmed
Bomberger, The deubiquitinating enzyme USP10 regulates the post-endocytic sorting of cystic fibrosis transmembrane conductance regulator in airway epithelial cells. 2009, Pubmed
Bomberger, A Pseudomonas aeruginosa toxin that hijacks the host ubiquitin proteolytic system. 2011, Pubmed
Bomberger, Methods to monitor cell surface expression and endocytic trafficking of CFTR in polarized epithelial cells. 2011, Pubmed
Bomberger, Arsenic promotes ubiquitinylation and lysosomal degradation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels in human airway epithelial cells. 2012, Pubmed
Caohuy, Rescue of DeltaF508-CFTR by the SGK1/Nedd4-2 signaling pathway. 2009, Pubmed
Cheng, Activation of PI3-kinase stimulates endocytosis of ROMK via Akt1/SGK1-dependent phosphorylation of WNK1. 2011, Pubmed
Cholon, Modulation of endocytic trafficking and apical stability of CFTR in primary human airway epithelial cultures. 2010, Pubmed
Clunes, Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. 2012, Pubmed
Cohen, Cystic fibrosis: a mucosal immunodeficiency syndrome. 2012, Pubmed
Farinha, Control of cystic fibrosis transmembrane conductance regulator membrane trafficking: not just from the endoplasmic reticulum to the Golgi. 2013, Pubmed
Fu, Dab2 is a key regulator of endocytosis and post-endocytic trafficking of the cystic fibrosis transmembrane conductance regulator. 2012, Pubmed
Gehring, PIKfyve upregulates CFTR activity. 2009, Pubmed , Xenbase
Gentzsch, Endocytic trafficking routes of wild type and DeltaF508 cystic fibrosis transmembrane conductance regulator. 2004, Pubmed
Guggino, New insights into cystic fibrosis: molecular switches that regulate CFTR. 2006, Pubmed
Heise, Serum and glucocorticoid-induced kinase (SGK) 1 and the epithelial sodium channel are regulated by multiple with no lysine (WNK) family members. 2010, Pubmed
Kim, Inhibitory regulation of cystic fibrosis transmembrane conductance regulator anion-transporting activities by Shank2. 2004, Pubmed
Koeppen, Nedd4-2 does not regulate wt-CFTR in human airway epithelial cells. 2012, Pubmed , Xenbase
Lang, Regulation of ion channels by the serum- and glucocorticoid-inducible kinase SGK1. 2013, Pubmed
Lee, Dynamic regulation of cystic fibrosis transmembrane conductance regulator by competitive interactions of molecular adaptors. 2007, Pubmed
Li, CFTR chloride channel in the apical compartments: spatiotemporal coupling to its interacting partners. 2010, Pubmed
Madshus, Internalization and intracellular sorting of the EGF receptor: a model for understanding the mechanisms of receptor trafficking. 2009, Pubmed
Mayle, The intracellular trafficking pathway of transferrin. 2012, Pubmed
Okamoto, Dynamin isoform-specific interaction with the shank/ProSAP scaffolding proteins of the postsynaptic density and actin cytoskeleton. 2001, Pubmed
Okiyoneda, Peripheral protein quality control removes unfolded CFTR from the plasma membrane. 2010, Pubmed
Prota, Dexamethasone regulates CFTR expression in Calu-3 cells with the involvement of chaperones HSP70 and HSP90. 2012, Pubmed
Rossi, Low doses of dexamethasone constantly delivered by autologous erythrocytes slow the progression of lung disease in cystic fibrosis patients. 2004, Pubmed
Rubenstein, Regulation of endogenous ENaC functional expression by CFTR and ΔF508-CFTR in airway epithelial cells. 2011, Pubmed
Saad, High glucose transactivates the EGF receptor and up-regulates serum glucocorticoid kinase in the proximal tubule. 2005, Pubmed
Sato, Regulation of human cystic fibrosis transmembrane conductance regulator (CFTR) by serum- and glucocorticoid-inducible kinase (SGK1). 2007, Pubmed , Xenbase
Shaw, The role of SGK and CFTR in acute adaptation to seawater in Fundulus heteroclitus. 2008, Pubmed , Xenbase
Shaw, Arsenic inhibits SGK1 activation of CFTR Cl- channels in the gill of killifish, Fundulus heteroclitus. 2010, Pubmed
Swiatecka-Urban, Myosin VI regulates endocytosis of the cystic fibrosis transmembrane conductance regulator. 2004, Pubmed
Swiatecka-Urban, The short apical membrane half-life of rescued {Delta}F508-cystic fibrosis transmembrane conductance regulator (CFTR) results from accelerated endocytosis of {Delta}F508-CFTR in polarized human airway epithelial cells. 2005, Pubmed
Swiatecka-Urban, Myosin Vb is required for trafficking of the cystic fibrosis transmembrane conductance regulator in Rab11a-specific apical recycling endosomes in polarized human airway epithelial cells. 2007, Pubmed
Tomas, EGF receptor trafficking: consequences for signaling and cancer. 2014, Pubmed
Van Goor, Rescue of CF airway epithelial cell function in vitro by a CFTR potentiator, VX-770. 2009, Pubmed
Van Goor, Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809. 2011, Pubmed
Wagner, Effects of the serine/threonine kinase SGK1 on the epithelial Na(+) channel (ENaC) and CFTR: implications for cystic fibrosis. 2001, Pubmed , Xenbase
Weixel, Mu 2 binding directs the cystic fibrosis transmembrane conductance regulator to the clathrin-mediated endocytic pathway. 2001, Pubmed
Ye, c-Cbl facilitates endocytosis and lysosomal degradation of cystic fibrosis transmembrane conductance regulator in human airway epithelial cells. 2010, Pubmed
Young, Dynasore inhibits removal of wild-type and DeltaF508 cystic fibrosis transmembrane conductance regulator (CFTR) from the plasma membrane. 2009, Pubmed